Absorption |
Blood-Brain Barrier | BBB+ | 0.9734 |
Human Intestinal Absorption | HIA+ | 0.9926 |
Caco-2 Permeability | Caco2+ | 0.6877 |
P-glycoprotein Substrate | Non-substrate | 0.8283 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9445 |
Non-inhibitor | 0.9289 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9304 |
Distribution |
Subcellular localization | Mitochondria | 0.6149 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8165 |
CYP450 2D6 Substrate | Non-substrate | 0.9385 |
CYP450 3A4 Substrate | Non-substrate | 0.7102 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8607 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9544 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9720 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9537 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9828 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9136 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9735 |
Non-inhibitor | 0.9856 |
AMES Toxicity | Non AMES toxic | 0.7896 |
Carcinogens | Carcinogens | 0.6490 |
Fish Toxicity | High FHMT | 0.6624 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6135 |
Honey Bee Toxicity | High HBT | 0.8865 |
Biodegradation | Ready biodegradable | 0.7597 |
Acute Oral Toxicity | III | 0.8920 |
Carcinogenicity (Three-class) | Non-required | 0.6779 |